why choose us

First received: November 27, 2022

Clinical Trial: Minimally Invasive Nasal Trabeculostomy - Performance and Safety Evaluation Study

Study Status: Completed

Recruit Status: RECRUITING

Condition: This Study is Obtained Under Inclusion/ Exclusion Criteria

Study Type: INTERVENTIONAL


Official Title: Minimally Invasive Nasal Trabeculostomy - Performance and Safety Evaluation Study

Brief Summary: Minimally Invasive Nasal Trabeculostomy System is intended for the reduction of elevated Intraocular Pressure (IOP).The system is a powered surgical device, designed to create trabeculostomy openings of ~100 microns diameter each, via an ab-interno approach, directly from the anterior chamber (AC) into Schlemm's canal (SC) by removing segments of the trabecular meshwork (TM) (i.e., an ab-interno nasal trabeculostomy).The ab-interno approach aims to decrease IOP by increasing aqueous outflow through a direct…

Read more